SC-49483

N/A

Report date: 2024/06/27 20:00:09
NME

Base Information

Drug NameSC-49483
Drug Alias NameSC-49483
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMaltase-glucoamylase inhibitors
TargetsMaltase-glucoamylase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)G.D. Searle Llc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A